May 2010Confidential © Aagami Inc. -

Aagami, Inc.

Strategic Consulting Services

LifeSciences Catalyst

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Aagami, Inc.

A life sciences services company based in suburbs

of Chicago, offers

Strategic Consulting Services

Drug Development Services Phase I to Phase IV clinical studies

BA, BE and PK/PD studies

Technology Licensing Services

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Strategic Consulting Services

Investments to and from India

In-Licensing or Out-Licensing

Mergers & Acquisitions targets

Finding the Right

JV partners and/or Distributors

CRO and CRAMS providers

Contract Sales/Marketing companies

Contract Manufacturing companies

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Needs of Mid and Small US firms

Investments for product development

Partnerships for co-development and

marketing

Cost effective Service providers for

product Development and Manufacturing

Contract Sales and Marketing companies

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Indian Industry Snapshot

4th Largest Pharma market (by volume)

Top 100 companies are present in 50+ countries

Top 20 have presence in Regulated markets

Globally successful in Generics

Looking to differentiate generic portfolio

Developing Innovative products portfolio

Increasingly seeking global market share

Therefore, hungry to acquire companies and

technologies globally, especially in regulated

markets

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Indian Firms are targeting

Acquisitions for

Innovative compounds and technologies

Companies in Regulated markets

Novel Drug Delivery Systems

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Indian Service Providers bring

Quality Services for FDA Approvals:GCP, GLP & GMP (as per US-FDA standards)

Largest # USFDA Approved GMP facilities

Highest # of DMF filings

Speedier Development Processes:

Large number of Experienced Scientists

Well established and mature Industry

Cost Effective Solutions:

PPP with US is 1:5 – As per World Bank

Easy availability of skilled human resources

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Aagami brings

Extensive Experience in the US Biotech,

Pharmaceutical and Medical Device industry

Understanding of ways of working (business

culture) & Deal experience with Indian industry

Extensive network with top 100 Indian LS

companies at CXO levels

Global Licensing and Investing Experience

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Sample list of assignments Finding partner to manufacture Peptides for a EU conglomerate

In-Licensing Oncology and Immunology NCEs for the pioneer of Biotech

Out-Licensing and Investing in a Intranasal Drug Delivery Device company from West coast of US

Licensing Bioavailability enhancers for a CA company

Strategic Investment in or Licensing the Oral Controlled Release technology of a CT company

Strategic Investments in an Ophthalmic Medical Device of a Mid-West company; Term sheet signed

Licensing for a new dermatology delivery system, applicable to both pharmaceutical and personal care products.

Licensing and Investment for a Southern US company with GI safe NSAIDs

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Sample List of Clients

Solvay Organics

Penwest Pharmaceuticals

Aegis Therapeutics

ScyFIX

Agile Therapeutics

Kurve Technologies

The pioneer of Biotech

Phosphagenics

PLx Pharma

May 2010Confidential © Aagami Inc. -

Dedicated promotion

Small retainer fee

Success fee based on the Lehman’s

How we do it

Confidential © Aagami Inc.- May 2010Life Sciences Catalyst

Key people

Dinesh JainA business leader in Science and technology industry for over 26 years with global experience in starting and managing several technology companies. Has held positions of CEO, President, Vice President. Is a prolific entrepreneur, Board member and speaker at international business conferences. Has executed several dozen international deals in 3 continents.

Mahendra ShahA veteran Scientific leader of 41 years in Bio-Pharmaceutical field. After his PhD, he has worked with some of the top notch companies like Bristol, Squibb, Schering, Lyphomed, Fujisawa. Mahendra has been an active Investor in BioPharmaceutical field and is on the Board of several companies across the country. At present he is CEO of Next Wave Pharmaceuticals.

Shridhar AndurkarChair and Associate Professor of Pharmaceutical sciences at Midwestern University, Chicago College of Pharmacy, is a Ph D from Auburn University in Medicinal Chemistry, Conducted postdoctoral research at the University of Houston. Dr. Andurkar has published numerous papers and made several presentations in this field. He holds a US patent in the area of anticonvulsant drugs. Is on the advisory boards of several companies.

May 2010Confidential © Aagami Inc. -

Aagami, Inc.

2020 Calamos Ct, Suite 209

Naperville, IL 60564

Phone: (630) 799-1572

dinesh@aagami.net

www.aagami.net

Enabling Strategic Partnerships